Remote smell tests to track early Alzheimer’s health changes
Part of Brain & nervous system, Mental health clinical trials.
This trial uses remote, at-home (or remote) smell-based testing to help researchers assess health in people with preclinical Alzheimer’s disease and in control participants. It may help by showing how well smell-related changes can signal disease status over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years old or older when you enroll (and no older than 100).
- Have a confirmed diagnosis of Alzheimer’s before symptoms or be a control participant (no Alzheimer’s).
- Do not have uncontrolled lung problems like severe emphysema or asthma that isn’t well managed.
- Do not currently have a cold, sinus infection, sinus inflammation, or nasal polyps.
- You should not be pregnant and must be able to complete the smell tests.
- You should not currently use substances/alcohol dependence; alcohol/substance abuse history alone isn’t automatically disqualifying.
- You should not have a strong bad reaction to fragrances (like severe asthma flare or severe nausea).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks for signs of Alzheimer’s disease in the brain by using memory and thinking tests, and related study procedures. It may help researchers find better ways to identify Alzheimer’s-related changes earlier.
This trial uses pleasant scents (aromatherapy) to see if they can improve mood and behavior for people with early memory loss. It is designed for individuals who have a caregiver who can help them participate.
This trial tests whether daily scent training can help improve memory and thinking in people with mild cognitive impairment (MCI), a condition that is more than normal aging but not dementia. You would smell different odors at home and track your progress.
This study is testing whether simple digital memory tests and blood tests can help find people who might qualify for anti-amyloid treatments (medications that target Alzheimer's-related proteins). It aims to make screening easier and faster, without needing a spinal tap or PET scan.
This study is looking for healthy volunteers to help detect the very earliest signs of Alzheimer's disease—before memory loss starts. You will have tests like memory checks, blood draws, brain scans, and a spinal tap to look for Alzheimer's-related changes.
This study follows people with normal thinking, early memory problems, or Alzheimer's disease to understand how the brain changes over time. Researchers will use smell tests, blood work, and memory testing to learn more about these conditions and potentially help future treatments.
Hear when a new Mild Cognitive Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.